ROSEN, LEADING INVESTOR COUNSEL, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action

Important Deadline Reminder for The Beauty Health Company Investors

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline.

What You Need to Know

Investors who purchased securities of The Beauty Health Company during the class period may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

The lawsuit alleges that The Beauty Health Company made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing delayed shipments of certain products due to production issues; (2) the Company was experiencing regulatory delays in launching certain products; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you suffered a loss in The Beauty Health Company, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

How This Will Affect You

As an investor in The Beauty Health Company during the specified class period, it is important to be aware of this securities class action and the lead plaintiff deadline. Failure to take action before the deadline could result in a loss of potential compensation.

How This Will Affect the World

The outcome of this securities class action against The Beauty Health Company could have broader implications for the world of investing and corporate accountability. Successful resolution of the case may set a precedent for holding companies accountable for their public statements and disclosures, ultimately benefiting investors and promoting transparency in the market.

Conclusion

Investors in The Beauty Health Company should take note of the ongoing securities class action and the upcoming lead plaintiff deadline. Seeking counsel before the deadline is crucial in protecting your rights and potential compensation. The outcome of this case could have far-reaching effects on the world of investing and corporate accountability, underscoring the importance of transparency and honesty in the market.